Wellbutrin
Metabolism
AstraZenecaPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Metabolism cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Recombinant Human Bnp VA Office of Research and Development | Phase 4 | B |
Omeprazole AstraZeneca | Phase 1 | CC |
Bilirubin AstraZeneca | Phase 1 | CC |
azd3480 AstraZeneca | Phase 1 | CC |
Rosiglitazone AstraZeneca | Phase 1 | CC |
CAFFEINE AstraZeneca | Phase 1 | CC |
LIPOPOLYSACCHARIDE University of Aarhus | N/A | D |
Dietpro Johns Hopkins Bloomberg School of Public Health | N/A | D |
Same molecule, other indications
Wellbutrin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →